Dementia Dilemma: How To Think About Aduhelm, The New FDA Approved Alzheimer’s Drug
June 9, 2021
It’s been almost 2 decades since the FDA approved any new therapeutics for the treatment of Alzheimer’s Disease. In that time, patients and families – as well as their care providers- have struggled with the reality of limited benefit from current medication options and a failure rate of 98.5% of…
Reverse Course: The Latest Research On Slowing Down The Aging Process
June 2, 2021
While there may be no desire to return to our 20s or 30s, many of us wouldn’t mind if we could just slow down the aging process a bit: maybe forestall some of the aches and pains that seem to arise anew every few months, or lessen the challenges of…
Expert Advice: Recent Insights And Recommendations From COVID-19 Experts
September 16, 2020
We’re more than 6 months into the Coronavirus pandemic and our understanding of the virus, it’s impact, and strategies to keep ourselves safe continue to evolve. And now, added to this mix are a range of articles and alarms about vaccine development and second waves. It’s no wonder, then, that…
Test Appeal: Accurate New Blood Test For Alzheimer’s Within Sight
August 12, 2020
Receiving a diagnosis of Alzheimer’s is often the end result of a long and difficult process begun when memory or cognition begins to deteriorate and when other types of dementia are ruled out. What’s more, by the time a diagnosis is made there are likely few effective therapeutic options for…
Time For A Change? Ageist Stereotypes Are Commonplace and Concerning During COVID-19
July 22, 2020
While the news about the coronavirus and older adults continues to be worrisome, what’s also disturbing is the continued presence of ageist stereotypes and our portrait of older adults during the coronavirus pandemic. In fact, as a group of noted geriatricians and gerontologists recently proclaimed, “Older adults have shown remarkable…
